Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Clinical trial NCT03715153 · TERMINATED
Trial details
- NCT number
- NCT03715153
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2021-10-26
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.